CARTERRA INC

Carterra Inc. specializes in the design, manufacturing, and sustained operational support of high-performance surface plasmon resonance (SPR) instrumentation, particularly the LSA XT platform, used for real-time biomolecular interaction analysis in research and diagnostics. Their core capabilities encompass precision instrument manufacturing, calibration, and mission-critical service maintenance for analytical laboratory systems, with deep expertise in SPR technology, microfluidics, optical sensing, and automated data acquisition workflows. The company provides end-to-end lifecycle support—from initial deployment to emergency repairs and annual service agreements—ensuring continuous instrument uptime for high-throughput research environments focused on infectious disease, immunology, and biopharmaceutical development. Their technical differentiation lies in domain-specific knowledge of SPR-based binding kinetics and the ability to maintain complex, sensitive optical systems under rigorous federal research standards. Carterra Inc. maintains a consistent and exclusive relationship with the Department of Health and Human Services, delivering both new instrumentation and ongoing technical services to support public health research initiatives. Their work directly enables HHS-funded laboratories to conduct real-time analysis of antibody-antigen interactions, viral protein dynamics, and therapeutic candidate screening, particularly in influenza and other pathogen studies. The company operates primarily under NAICS 334516 for analytical laboratory instrument manufacturing and 811210 for precision equipment repair and maintenance, positioning itself at the intersection of life sciences instrumentation and federal research infrastructure. Carterra is not certified under any government small business programs and is headquartered in Salt Lake City, Utah, serving as a niche supplier to federal biomedical research entities requiring specialized, high-precision instrumentation and expert service support.